Procarbazine
- Generic Name
- Procarbazine
- Brand Names
- Matulane
- Drug Type
- Small Molecule
- Chemical Formula
- C12H19N3O
- CAS Number
- 671-16-9
- Unique Ingredient Identifier
- 35S93Y190K
Overview
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Background
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Indication
For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease.
Associated Conditions
- Non-Hodgkin's Lymphoma (NHL)
- Oligodendroglioma
- Primary Central Nervous System Lymphoma
- Stage III Hodgkin's Disease
- Stage IV Hodgkin's Disease
Clinical Trials
FDA Approved Products
Matulane
Manufacturer:Leadiant Biosciences, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2023/11/20
NDC:54482-054
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath